Annovis Bio Stock Earnings Per Share
| ANVS Stock | USD 6.54 0.02 0.30% |
Annovis Bio fundamentals help investors to digest information that contributes to Annovis Bio's financial success or failures. It also enables traders to predict the movement of Annovis Stock. The fundamental analysis module provides a way to measure Annovis Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Annovis Bio stock.
Annovis | Earnings Per Share |
Annovis Bio Company Earnings Per Share Analysis
Annovis Bio's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Annovis Bio Earnings Per Share | (4.22) X |
Most of Annovis Bio's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Annovis Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Annovis Earnings Per Share Driver Correlations
Understanding the fundamental principles of building solid financial models for Annovis Bio is extremely important. It helps to project a fair market value of Annovis Stock properly, considering its historical fundamentals such as Earnings Per Share. Since Annovis Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Annovis Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Annovis Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
Annovis Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
According to the company disclosure, Annovis Bio has an Earnings Per Share of -4.22 times. This is 150.42% lower than that of the Biotechnology sector and 11.9% lower than that of the Health Care industry. The earnings per share for all United States stocks is notably higher than that of the company.
Annovis Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Annovis Bio's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Annovis Bio could also be used in its relative valuation, which is a method of valuing Annovis Bio by comparing valuation metrics of similar companies.Annovis Bio is currently under evaluation in earnings per share category among its peers.
Annovis Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Annovis Bio from analyzing Annovis Bio's financial statements. These drivers represent accounts that assess Annovis Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Annovis Bio's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 43.2M | 47.6M | 134.1M | 109.6M | 98.7M | 55.8M | |
| Enterprise Value | 43.6M | 39.5M | 88.4M | 81.2M | 73.1M | 44.9M |
Annovis Bio ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Annovis Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Annovis Bio's managers, analysts, and investors.Environmental | Governance | Social |
Annovis Fundamentals
| Return On Equity | -5.97 | ||||
| Return On Asset | -1.55 | ||||
| Current Valuation | 77.87 M | ||||
| Shares Outstanding | 13.8 M | ||||
| Shares Owned By Insiders | 20.40 % | ||||
| Shares Owned By Institutions | 8.83 % | ||||
| Number Of Shares Shorted | 1.39 M | ||||
| Price To Earning | (0.43) X | ||||
| Price To Book | 12.81 X | ||||
| EBITDA | (45.04 M) | ||||
| Net Income | (56.2 M) | ||||
| Cash And Equivalents | 35.97 M | ||||
| Cash Per Share | 4.41 X | ||||
| Total Debt | 17.96 M | ||||
| Debt To Equity | (0.31) % | ||||
| Current Ratio | 28.11 X | ||||
| Book Value Per Share | 0.53 X | ||||
| Cash Flow From Operations | (39.97 M) | ||||
| Short Ratio | 4.02 X | ||||
| Earnings Per Share | (4.22) X | ||||
| Target Price | 34.8 | ||||
| Beta | 1.7 | ||||
| Market Capitalization | 90.51 M | ||||
| Total Asset | 10.21 M | ||||
| Retained Earnings | (110.26 M) | ||||
| Working Capital | 5.93 M | ||||
| Current Asset | 986 K | ||||
| Current Liabilities | 216 K | ||||
| Net Asset | 10.21 M |
About Annovis Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Annovis Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Annovis Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Annovis Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Annovis Stock Analysis
When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.